Assessment name | Pre-SCR | SCR | BSL | 8 w | 12 w | 3M | 16 w | 20 w | 6M | 9M | 12M | 15M | 18M | As clinically prescribed |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Point-of-care HIV, HCV, and pregnancy rapid testing | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
Hepatitis A virus test, anti-HBs, anti-HBc | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
Pregnancy and birth control assessment | Â | X | X | Â | Â | X | Â | Â | X | X | X | X | X | Â |
Medical and psychiatric history | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Physical exams and vital signs | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
HCV Ab, HCV RNA | Â | X | X | Â | Â | X | Â | Â | X | X | X | X | X | X |
Liver and kidney function | Â | X | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
HIV, syphilis, chlamydia, gonorrhea, and hepatitis B | Â | Â | X | Â | Â | X | Â | Â | X | X | X | X | X | Â |
Concomitant medications | Â | Â | X | Â | Â | X | Â | Â | X | X | X | X | X | Â |
Adverse events and serious adverse events | Â | Â | X | Â | Â | X | Â | Â | X | X | X | X | X | Â |
Treatment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Clinical management | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
Dried blood spot | Â | Â | X | X | X | Â | X | X | X | X | X | X | X | Â |
HCV treated participants | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
HCV RNA | 12w post-Tx initiation, 12w post-end of treatment |